BRPI0507233A - processo de produção de polipeptìdeo heterólogo em e.coli - Google Patents
processo de produção de polipeptìdeo heterólogo em e.coliInfo
- Publication number
- BRPI0507233A BRPI0507233A BRPI0507233-6A BRPI0507233A BRPI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A
- Authority
- BR
- Brazil
- Prior art keywords
- coli
- production process
- polypeptide
- heterologous polypeptide
- polypeptide production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
PROCESSO DE PRODUçãO DE POLIPEPTìDEO HETERóLOGO EM E. COLI é descrito um processo de produção de polipeptídeo heterólogo a E. coli, em que as células de E. coli compreendem ácido nucléico codificador do polipeptídeo são cultivadas em meio de cultivo mediante alimentação ao meio de cultivo de organofosfato transportável, de tal forma que o ácido nucléico seja expresso. O polipeptídeo é recuperado das células em seguida.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55267804P | 2004-03-11 | 2004-03-11 | |
| US60/552,678 | 2004-03-11 | ||
| PCT/US2005/007880 WO2005087802A2 (en) | 2004-03-11 | 2005-03-10 | Process for producing polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0507233A true BRPI0507233A (pt) | 2007-06-26 |
| BRPI0507233B1 BRPI0507233B1 (pt) | 2018-01-23 |
| BRPI0507233B8 BRPI0507233B8 (pt) | 2021-05-25 |
Family
ID=34976293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0507233A BRPI0507233B8 (pt) | 2004-03-11 | 2005-03-10 | processo para a produção de um polipeptídeo heterólogo em e. coli |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US7294483B2 (pt) |
| EP (1) | EP1733037B1 (pt) |
| JP (1) | JP5014116B2 (pt) |
| KR (1) | KR101210083B1 (pt) |
| CN (1) | CN1954074B (pt) |
| AU (1) | AU2005222397A1 (pt) |
| BR (1) | BRPI0507233B8 (pt) |
| CA (2) | CA2558911C (pt) |
| DK (1) | DK1733037T3 (pt) |
| ES (1) | ES2527291T3 (pt) |
| HR (1) | HRP20150077T1 (pt) |
| IL (1) | IL177488A0 (pt) |
| ME (1) | ME02058B (pt) |
| NZ (1) | NZ549266A (pt) |
| PL (1) | PL1733037T3 (pt) |
| PT (1) | PT1733037E (pt) |
| RS (1) | RS53774B1 (pt) |
| RU (1) | RU2433185C2 (pt) |
| SI (1) | SI1733037T1 (pt) |
| WO (1) | WO2005087802A2 (pt) |
| ZA (1) | ZA200606913B (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0507233B8 (pt) * | 2004-03-11 | 2021-05-25 | Genentech Inc | processo para a produção de um polipeptídeo heterólogo em e. coli |
| US8340883B2 (en) * | 2005-09-15 | 2012-12-25 | Continental Teves Ag & Co. Ohg | Method and apparatus for predicting a movement trajectory |
| JP2009095237A (ja) | 2006-02-02 | 2009-05-07 | Ajinomoto Co Inc | Ｌ−アミノ酸の製造法 |
| SG11201404991YA (en) | 2012-02-23 | 2014-09-26 | Stage Cell Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
| JP6787894B2 (ja) | 2014-12-05 | 2020-11-18 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 組換えアルカリホスファターゼを用いた発作の処置 |
| CA2973883A1 (en) | 2015-01-28 | 2016-08-04 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| JP6993961B2 (ja) * | 2015-08-17 | 2022-01-14 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼの製造 |
| MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
| RU2761555C2 (ru) | 2015-10-22 | 2021-12-09 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| EP3368062A4 (en) | 2015-10-30 | 2019-07-03 | Alexion Pharmaceuticals, Inc. | METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT |
| KR20180125979A (ko) | 2016-04-01 | 2018-11-26 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼리성 포스파타아제로 근육 약화의 치료 |
| KR20190129058A (ko) | 2017-03-31 | 2019-11-19 | 알렉시온 파마슈티칼스, 인코포레이티드 | 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법 |
| AU2018260380B2 (en) | 2017-04-27 | 2025-02-13 | Juno Therapeutics Gmbh | Oligomeric particle reagents and methods of use thereof |
| WO2019190752A1 (en) | 2018-03-30 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | Manufacturing of glycoproteins |
| WO2020033867A2 (en) | 2018-08-10 | 2020-02-13 | Alexion Pharmaceuticals, Inc. | Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase |
| WO2020089343A1 (en) | 2018-10-31 | 2020-05-07 | Juno Therapeutics Gmbh | Methods for selection and stimulation of cells and apparatus for same |
| CA3161266A1 (en) | 2019-12-09 | 2021-06-17 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| US12611447B2 (en) | 2020-09-04 | 2026-04-28 | Alexion Pharmaceuticals, Inc. | Methods for treating bone mineralization disorders |
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery |
| US12453805B2 (en) | 2020-09-24 | 2025-10-28 | Everest Medical Innovation GmbH | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery |
| AU2022218782B2 (en) | 2021-02-12 | 2026-06-25 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| CN113308393A (zh) * | 2021-04-20 | 2021-08-27 | 上田环境修复有限公司 | 一种降解氨氮和总氮的制剂及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304472A (en) * | 1992-11-20 | 1994-04-19 | Genentech, Inc. | Method of controlling polypeptide production in bacterial cells |
| US5342763A (en) * | 1992-11-23 | 1994-08-30 | Genentech, Inc. | Method for producing polypeptide via bacterial fermentation |
| CN1266275C (zh) * | 1995-06-07 | 2006-07-26 | 丹尼斯科公司 | 重组己糖氧化酶和其产生方法及用途 |
| CA2225378C (en) | 1995-06-29 | 2012-04-17 | Immunex Corporation | Cytokine that induces apoptosis |
| US6030945A (en) | 1996-01-09 | 2000-02-29 | Genentech, Inc. | Apo-2 ligand |
| EP1001990A4 (en) | 1997-06-26 | 2001-12-19 | Immunex Corp | PROTEIN BINDING TO TRAIL PROTEIN |
| RU2139343C1 (ru) * | 1997-10-31 | 1999-10-10 | Государственный научный центр прикладной микробиологии | Питательная среда для выделения возбудителя геморрагического колита с гемолитико-уремическим синдромом, вызываемого кишечной палочкой 0157:н7 (сорбитол e.coli 0157:н7агар) |
| WO2000055353A1 (en) * | 1999-03-17 | 2000-09-21 | The Board Of Trustees Of The Leland Stanford Junior University | In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| US6337191B1 (en) * | 1999-03-22 | 2002-01-08 | The Board Of Trustees Of The Leland Stanford Junior University | Vitro protein synthesis using glycolytic intermediates as an energy source |
| ES2208305T3 (es) * | 1999-04-08 | 2004-06-16 | Genentech, Inc. | Composicion basada en polipeptidos de carga opuesta.. |
| EP1194555B1 (en) | 1999-06-28 | 2012-09-26 | Genentech, Inc. | Methods for making apo-2 ligand using divalent metal ions |
| RU2165455C1 (ru) * | 1999-11-23 | 2001-04-20 | Государственный научно-исследовательский институт особо чистых биопрепаратов | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pSS5, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА, ШТАММ ESCHERICHIA COLI SS5 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА И СПОСОБ ПОЛУЧЕНИЯ ИНТЕРФЕРОНА АЛЬФА-2b |
| EP1341802A4 (en) | 2000-11-14 | 2004-09-08 | Univ Leland Stanford Junior | IN VITRO SYNTHESIS OF PROTEINS USING GLYCOLYTIC INTERMEDIATES AS AN ENERGY SOURCE |
| HU225346B1 (en) * | 2001-09-13 | 2006-10-28 | Genentech Inc | Method for cleaving polipeptides |
| JP2006506985A (ja) * | 2002-10-30 | 2006-03-02 | ファイザー・プロダクツ・インク | コンパニオンアニマルのガンを診断および治療するための方法および組成物 |
| BRPI0507233B8 (pt) * | 2004-03-11 | 2021-05-25 | Genentech Inc | processo para a produção de um polipeptídeo heterólogo em e. coli |
-
2005
- 2005-03-10 BR BRPI0507233A patent/BRPI0507233B8/pt not_active IP Right Cessation
- 2005-03-10 ME MEP-2015-13A patent/ME02058B/me unknown
- 2005-03-10 AU AU2005222397A patent/AU2005222397A1/en not_active Abandoned
- 2005-03-10 CA CA2558911A patent/CA2558911C/en not_active Expired - Lifetime
- 2005-03-10 PT PT57251985T patent/PT1733037E/pt unknown
- 2005-03-10 CN CN2005800153788A patent/CN1954074B/zh not_active Expired - Lifetime
- 2005-03-10 US US11/077,272 patent/US7294483B2/en not_active Expired - Lifetime
- 2005-03-10 RU RU2006135933/10A patent/RU2433185C2/ru active
- 2005-03-10 JP JP2007502982A patent/JP5014116B2/ja not_active Expired - Fee Related
- 2005-03-10 NZ NZ549266A patent/NZ549266A/en not_active IP Right Cessation
- 2005-03-10 SI SI200531927T patent/SI1733037T1/sl unknown
- 2005-03-10 ES ES05725198.5T patent/ES2527291T3/es not_active Expired - Lifetime
- 2005-03-10 WO PCT/US2005/007880 patent/WO2005087802A2/en not_active Ceased
- 2005-03-10 CA CA2946323A patent/CA2946323A1/en not_active Abandoned
- 2005-03-10 ZA ZA200606913A patent/ZA200606913B/en unknown
- 2005-03-10 KR KR1020067018372A patent/KR101210083B1/ko not_active Expired - Fee Related
- 2005-03-10 RS RS20150072A patent/RS53774B1/sr unknown
- 2005-03-10 PL PL05725198T patent/PL1733037T3/pl unknown
- 2005-03-10 DK DK05725198.5T patent/DK1733037T3/en active
- 2005-03-10 HR HRP20150077TT patent/HRP20150077T1/hr unknown
- 2005-03-10 EP EP05725198.5A patent/EP1733037B1/en not_active Expired - Lifetime
-
2006
- 2006-08-15 IL IL177488A patent/IL177488A0/en unknown
- 2006-09-28 US US11/536,551 patent/US20070026496A1/en not_active Abandoned
-
2009
- 2009-09-16 US US12/586,023 patent/US8389242B2/en not_active Expired - Fee Related
-
2013
- 2013-03-01 US US13/782,973 patent/US20130236930A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0507233B8 (pt) | processo para a produção de um polipeptídeo heterólogo em e. coli | |
| WO2016183438A8 (en) | Self-targeting genome editing system | |
| MY153731A (en) | Recovery of higher alcohols from dilute aqueous solutions | |
| IN2014DN03419A (pt) | ||
| BR112012027282A2 (pt) | meio de cultura de células aperfeiçoado | |
| MX2012000251A (es) | Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas. | |
| IN2015DN01365A (pt) | ||
| IN2015DN01606A (pt) | ||
| AR090949A1 (es) | METODO DE USAR a-AMILASA DE ASPERGILLUS CLAVATUS PARA LA SACARIFICACION | |
| NZ600540A (en) | Ethanol production in non-recombinant hosts | |
| WO2010115201A3 (en) | Reactor system and method for processing a process fluid | |
| MY156181A (en) | Method and system for producing high-purity hydrogen chloride | |
| MX391164B (es) | Metodo para producir compuesto opticamente activo | |
| WO2008096723A1 (ja) | 六フッ化リン酸塩の製造方法 | |
| WO2012129962A8 (zh) | 一种联合制碱大循环工艺 | |
| WO2008126896A1 (ja) | 有機酸の製造方法 | |
| WO2013188305A3 (en) | Fungal beta-xylosidase variants | |
| BR112014030376A2 (pt) | processo para a produção de lactato | |
| MY185050A (en) | A pentose sugar fermenting cell | |
| WO2010064262A3 (en) | A process for production of water soluble melanin using a strain of the fungus gliocephalotrichum | |
| CA2858551C (en) | Method of maintaining the value of an alkylene oxide production parameter in a process of making an alkylene oxide using a high efficiency catalyst | |
| CA2894261C (en) | Alpha-amylases and polynucleotides encoding same | |
| ES2168971A1 (es) | Procedimiento de produccion de beta-caroteno. | |
| WO2013163292A3 (en) | Methods and microorganisms for increasing the biological synthesis of difunctional alkanes | |
| WO2009116066A3 (en) | A process for production of xylitol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2765 DE 02-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |